Novavax Vaccine Appears 86% Effective Against U.K's COVID-19 Variant

Vaccine maker Novavax is waiting for its COVID-19 vaccine to be approved in the U.K., and is hopeful that U.S. approval will follow. NPR's Steve Inskeep speaks to Novavax CEO Stanley Erck.

Check out CBD Shop or CBD Blog

Curated by Thc 420 Hemp

source https://www.npr.org/2021/03/02/972742628/novavax-vaccine-appears-86-effective-against-u-ks-covid-19-variant